Cargando…

Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study

BACKGROUND: Malaria in pregnancy is a major health problem that can cause maternal anaemia, stillbirth, spontaneous abortion, low birth weight and intra-uterine stunting. The WHO recommends use of sulphadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria during pregnancy (IPTp...

Descripción completa

Detalles Bibliográficos
Autores principales: Namusoke, Fatuma, Ntale, Muhammad, Wahlgren, Mats, Kironde, Fred, Mirembe, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457910/
https://www.ncbi.nlm.nih.gov/pubmed/22950456
http://dx.doi.org/10.1186/1475-2875-11-310
_version_ 1782244584243331072
author Namusoke, Fatuma
Ntale, Muhammad
Wahlgren, Mats
Kironde, Fred
Mirembe, Florence
author_facet Namusoke, Fatuma
Ntale, Muhammad
Wahlgren, Mats
Kironde, Fred
Mirembe, Florence
author_sort Namusoke, Fatuma
collection PubMed
description BACKGROUND: Malaria in pregnancy is a major health problem that can cause maternal anaemia, stillbirth, spontaneous abortion, low birth weight and intra-uterine stunting. The WHO recommends use of sulphadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria during pregnancy (IPTp) in endemic areas. Towards monitoring and assessing IPTp coverage in the population, the Roll Back Malaria Partnership recommends the use of self-reported data. The aim of this study was to assess the validity of self-reported IPTp by testing for sulphadoxine in maternal blood at delivery. METHODS: Two hundred and four pregnant women were consented and enrolled in a cross-sectional study in Mulago National Referral Hospital in Kampala Uganda. - Participants who reported a history of taking sulpha-containing drugs like co-trimoxazole , those who were not sure of dates relating to last menstrual period or who took IPTp within the first 20 weeks of gestation were excluded from the study. Data on demographic characteristics, obstetric history, and delivery outcome were collected. At birth, maternal venous blood was taken off aseptically and used to make thick blood smears for malaria parasites and plasma for determining sulphadoxine using high performance liquid chromatography (HPLC). RESULTS: Of 120 participants who self reported to have used IPTp, 35 (29.2%) tested positive for sulphadoxine by HPLC, while 63 (75%) of 84 patients who reported not having used IPTp tested negative for sulphadoxine. Participants possessing post-primary education were more likely to have reported using IPTp. The low agreement (kappa coefficient = 0.037) between self-report and actual presence of the drug in the blood casts doubt on the validity of self-reported data in estimating IPTp coverage. CONCLUSIONS: The results of this study question the accuracy of self-reported data in estimating IPTp coverage in the population. More studies on validity of self reported data are recommended. Since the validity of IPTp self reports is vital for guiding policy on malaria control in pregnancy, ways should be sought to improve accuracy of the information from such reports.
format Online
Article
Text
id pubmed-3457910
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34579102012-09-26 Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study Namusoke, Fatuma Ntale, Muhammad Wahlgren, Mats Kironde, Fred Mirembe, Florence Malar J Research BACKGROUND: Malaria in pregnancy is a major health problem that can cause maternal anaemia, stillbirth, spontaneous abortion, low birth weight and intra-uterine stunting. The WHO recommends use of sulphadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria during pregnancy (IPTp) in endemic areas. Towards monitoring and assessing IPTp coverage in the population, the Roll Back Malaria Partnership recommends the use of self-reported data. The aim of this study was to assess the validity of self-reported IPTp by testing for sulphadoxine in maternal blood at delivery. METHODS: Two hundred and four pregnant women were consented and enrolled in a cross-sectional study in Mulago National Referral Hospital in Kampala Uganda. - Participants who reported a history of taking sulpha-containing drugs like co-trimoxazole , those who were not sure of dates relating to last menstrual period or who took IPTp within the first 20 weeks of gestation were excluded from the study. Data on demographic characteristics, obstetric history, and delivery outcome were collected. At birth, maternal venous blood was taken off aseptically and used to make thick blood smears for malaria parasites and plasma for determining sulphadoxine using high performance liquid chromatography (HPLC). RESULTS: Of 120 participants who self reported to have used IPTp, 35 (29.2%) tested positive for sulphadoxine by HPLC, while 63 (75%) of 84 patients who reported not having used IPTp tested negative for sulphadoxine. Participants possessing post-primary education were more likely to have reported using IPTp. The low agreement (kappa coefficient = 0.037) between self-report and actual presence of the drug in the blood casts doubt on the validity of self-reported data in estimating IPTp coverage. CONCLUSIONS: The results of this study question the accuracy of self-reported data in estimating IPTp coverage in the population. More studies on validity of self reported data are recommended. Since the validity of IPTp self reports is vital for guiding policy on malaria control in pregnancy, ways should be sought to improve accuracy of the information from such reports. BioMed Central 2012-09-05 /pmc/articles/PMC3457910/ /pubmed/22950456 http://dx.doi.org/10.1186/1475-2875-11-310 Text en Copyright ©2012 Namusoke et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Namusoke, Fatuma
Ntale, Muhammad
Wahlgren, Mats
Kironde, Fred
Mirembe, Florence
Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study
title Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study
title_full Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study
title_fullStr Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study
title_full_unstemmed Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study
title_short Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study
title_sort validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (iptp): a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457910/
https://www.ncbi.nlm.nih.gov/pubmed/22950456
http://dx.doi.org/10.1186/1475-2875-11-310
work_keys_str_mv AT namusokefatuma validityofselfreporteduseofsulphadoxinepyrimethamineintermittentpresumptivetreatmentduringpregnancyiptpacrosssectionalstudy
AT ntalemuhammad validityofselfreporteduseofsulphadoxinepyrimethamineintermittentpresumptivetreatmentduringpregnancyiptpacrosssectionalstudy
AT wahlgrenmats validityofselfreporteduseofsulphadoxinepyrimethamineintermittentpresumptivetreatmentduringpregnancyiptpacrosssectionalstudy
AT kirondefred validityofselfreporteduseofsulphadoxinepyrimethamineintermittentpresumptivetreatmentduringpregnancyiptpacrosssectionalstudy
AT mirembeflorence validityofselfreporteduseofsulphadoxinepyrimethamineintermittentpresumptivetreatmentduringpregnancyiptpacrosssectionalstudy